NCT02064608View on ClinicalTrials.gov

Investigating the Effects of AZD2014 Therapy Given Prior to Radical Prostatectomy in Men With High Risk Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

June 30, 2018

Conditions
Prostate Cancer
Interventions
DRUG

AZD2014

mTOR inhibitor

Trial Locations (1)

CB2 0QQ

Cambridge University Hospitals NHS Foundation Trust, Cambridge

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER